Pre-Summer Special Limited Time 70% Discount Offer - Ends in 0d 00h 00m 00s - Coupon code: force70

Salesforce Certified Agentforce Life Sciences Consultant Als-Con-201 Question # 12 Topic 2 Discussion

Salesforce Certified Agentforce Life Sciences Consultant Als-Con-201 Question # 12 Topic 2 Discussion

Als-Con-201 Exam Topic 2 Question 12 Discussion:
Question #: 12
Topic #: 2

Choose 1 option.

Cumulus Pharma wants to launch a new product, “Immunexis,” and mandates that field sales reps must capture explicit opt-in consent from Healthcare Providers (HCPs) before sending any digital marketing materials. The following records are already configured in Agentforce Life Sciences:

Data Use Purpose record for “Immunexis Marketing”

Communication Subscription record named “Immunexis KOL Webinar Series”

Engagement Channel Type record for “Email”

When reps attempt to capture consent on their iPads, they can see the “Immunexis KOL Webinar Series” subscription, but they cannot select “Email” as a channel to capture the opt-in preference.

Which step resolves this issue so the rep can select “Email” for this subscription?


A.

Create a Communication Subscription Channel Type junction record to link the Subscription to the Engagement Channel Type.


B.

Create a Communication Subscription Consent record for the user profile to activate the channel visibility.


Get Premium Als-Con-201 Questions

Contribute your Thoughts:


Chosen Answer:
This is a voting comment (?). It is better to Upvote an existing comment if you don't have anything to add.